CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY - Get Free Report) was the recipient of a large increase in short interest during the month of September. As of September 15th, there was short interest totaling 5,000 shares, an increase of 163.2% from the August 31st total of 1,900 shares. Based on an average trading volume of 16,600 shares, the days-to-cover ratio is presently 0.3 days. Based on an average trading volume of 16,600 shares, the days-to-cover ratio is presently 0.3 days.
Analysts Set New Price Targets
A number of analysts recently weighed in on the stock. Citigroup lowered shares of CochLear to a "neutral" rating in a research note on Thursday, September 18th. UBS Group upgraded shares of CochLear from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, June 18th. Finally, Zacks Research upgraded shares of CochLear to a "hold" rating in a research note on Monday, August 11th. One research analyst has rated the stock with a Strong Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy".
Check Out Our Latest Report on CochLear
CochLear Stock Performance
CHEOY traded up $1.05 on Friday, reaching $93.84. The company's stock had a trading volume of 1,064 shares, compared to its average volume of 10,534. The stock has a 50 day moving average of $98.63 and a two-hundred day moving average of $92.30. CochLear has a fifty-two week low of $74.76 and a fifty-two week high of $105.60.
CochLear Dividend Announcement
The company also recently disclosed a dividend, which will be paid on Tuesday, October 28th. Stockholders of record on Monday, September 22nd will be issued a $0.1045 dividend. This represents a dividend yield of 122.0%. The ex-dividend date of this dividend is Friday, September 19th.
About CochLear
(
Get Free Report)
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CochLear, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CochLear wasn't on the list.
While CochLear currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
